Benzinga | Nov 9, 2021 11:08AM EST

Amphastar Pharmaceuticals Q3 EPS $0.46 Beats $0.24 Estimate, Sales $112.20M Beat $103.24M Estimate

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.24 by 91.67 percent. This is a 206.67 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $112.20 million which beat the analyst consensus estimate of $103.24 million by 8.68 percent. This is a 34.48 percent increase over sales of $83.43 million the same period last year.